India · Delayed Price · Currency is INR Medicamen Organics Statistics
Total Valuation
NSE:MEDIORG has a market cap or net worth of INR 251.55 million. The enterprise value is 380.04 million.
| Market Cap | 251.55M |
| Enterprise Value | 380.04M |
Important Dates
The last earnings date was Friday, May 29, 2026.
| Earnings Date | May 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NSE:MEDIORG has 11.70 million shares outstanding. The number of shares has increased by 6.61% in one year.
| Current Share Class | 11.70M |
| Shares Outstanding | 11.70M |
| Shares Change (YoY) | +6.61% |
| Shares Change (QoQ) | -0.47% |
| Owned by Insiders (%) | 62.34% |
| Owned by Institutions (%) | n/a |
| Float | 4.41M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.11 |
| PB Ratio | 0.88 |
| P/TBV Ratio | 0.89 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.68 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.69, with a Debt / Equity ratio of 0.50.
| Current Ratio | 1.69 |
| Quick Ratio | 0.92 |
| Debt / Equity | 0.50 |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.26 |
| Interest Coverage | -6.55 |
Financial Efficiency
Return on equity (ROE) is -13.61% and return on invested capital (ROIC) is -11.18%.
| Return on Equity (ROE) | -13.61% |
| Return on Assets (ROA) | -5.24% |
| Return on Invested Capital (ROIC) | -11.18% |
| Return on Capital Employed (ROCE) | -15.56% |
| Weighted Average Cost of Capital (WACC) | 9.61% |
| Revenue Per Employee | 1.99M |
| Profits Per Employee | -352,579 |
| Employee Count | 114 |
| Asset Turnover | 0.41 |
| Inventory Turnover | 2.07 |
Taxes
| Income Tax | -12.59M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -54.21% in the last 52 weeks. The beta is 1.56, so NSE:MEDIORG's price volatility has been higher than the market average.
| Beta (5Y) | 1.56 |
| 52-Week Price Change | -54.21% |
| 50-Day Moving Average | 25.10 |
| 200-Day Moving Average | 29.24 |
| Relative Strength Index (RSI) | 42.89 |
| Average Volume (20 Days) | 19,600 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:MEDIORG had revenue of INR 226.30 million and -40.19 million in losses. Loss per share was -3.41.
| Revenue | 226.30M |
| Gross Profit | 40.32M |
| Operating Income | -46.48M |
| Pretax Income | -52.78M |
| Net Income | -40.19M |
| EBITDA | -40.28M |
| EBIT | -46.48M |
| Loss Per Share | -3.41 |
Balance Sheet
The company has 13.03 million in cash and 142.93 million in debt, with a net cash position of -129.90 million or -11.10 per share.
| Cash & Cash Equivalents | 13.03M |
| Total Debt | 142.93M |
| Net Cash | -129.90M |
| Net Cash Per Share | -11.10 |
| Equity (Book Value) | 285.87M |
| Book Value Per Share | 24.22 |
| Working Capital | 151.07M |
Cash Flow
In the last 12 months, operating cash flow was -45.95 million and capital expenditures -17.38 million, giving a free cash flow of -63.34 million.
| Operating Cash Flow | -45.95M |
| Capital Expenditures | -17.38M |
| Depreciation & Amortization | 6.20M |
| Net Borrowing | 19.40M |
| Free Cash Flow | -63.34M |
| FCF Per Share | -5.41 |
Margins
Gross margin is 17.82%, with operating and profit margins of -20.54% and -17.76%.
| Gross Margin | 17.82% |
| Operating Margin | -20.54% |
| Pretax Margin | -23.32% |
| Profit Margin | -17.76% |
| EBITDA Margin | -17.80% |
| EBIT Margin | -20.54% |
| FCF Margin | n/a |
Dividends & Yields
NSE:MEDIORG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.61% |
| Shareholder Yield | -6.61% |
| Earnings Yield | -15.98% |
| FCF Yield | -25.18% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |